On 8/23/24, Catalyst Biosciences Inc (NASDAQ: CBIO) stock enjoyed a major increase of 11.9%, closing at $12.84. However, below average trading volume at 74% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 20.2% during the last week.
Current PriceTarget Research Rating
CBIO is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment